Sunshine Biopharma, Inc. (SBFMW)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Steve N. Slilaty Ph.D. | Chairman, President & CEO | 1.29M | -- | 1952 |
Mr. Camille Sebaaly | CFO & Secretary | 352.03k | -- | 1959 |
Dr. Abderrazzak Merzouki | COO & Director | 366.62k | -- | 1964 |
Mr. Malek Chamoun | Chief Development Officer | -- | -- | 1985 |
Mr. Michel Roy | Chief Commercial Officer | -- | -- | 1968 |
Mr. Robert G. Ferreira | President of Sunshine Bio Investments Inc | -- | -- | 1962 |
Sunshine Biopharma, Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 52
Description
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available